Alector to Participate in Upcoming Healthcare Conferences

Company Overview - Alector, Inc. is a clinical-stage biotechnology company focused on immuno-neurology, which is a novel therapeutic approach for treating neurodegenerative diseases [2] - The company targets immune dysfunction as a root cause of various pathologies that drive degenerative brain disorders [2] - Alector is developing a portfolio of innate immune system programs aimed at repairing genetic mutations that cause brain immune system dysfunction [2] Upcoming Events - Alector will participate in several investor conferences, including: - TD Cowen 44th Annual Health Care Conference on March 5, 2024, at 10:30 a.m. ET [1] - Leerink Partners Global Biopharma Conference on March 12, 2024, at 10:40 a.m. ET [1] - Barclays 26th Annual Global Healthcare Conference on March 13, 2024, at 2:05 p.m. ET [1] - Stifel 2024 CNS Days (Virtual) on March 19, 2024, at 11:30 a.m. ET [1] - Webcasts of each conference presentation will be available on Alector's website, with replays accessible for 90 days post-presentation [1]